California State Teachers Retirement System (CalSTRS)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,670
Closed -$75K 3336
2022
Q1
$75K Sell
15,670
-3,908
-20% -$11.8K ﹤0.01% 2943
2021
Q4
$71K Hold
19,578
﹤0.01% 3090
2021
Q3
$157K Sell
19,578
-30,404
-61% -$300K ﹤0.01% 2838
2021
Q2
$567K Buy
+49,982
New +$502K ﹤0.01% 2577
2015
Q2
Sell
-491
Closed -$253K 3046
2015
Q1
$253K Buy
491
+54
+12% +$27.2K ﹤0.01% 2807
2014
Q4
$234K Buy
437
+2
+0.5% +$901 ﹤0.01% 2881
2014
Q3
$652K Buy
435
+5
+1% +$7.24K ﹤0.01% 2279
2014
Q2
$589K Buy
430
+104
+32% +$121K ﹤0.01% 2405
2014
Q1
$453K Buy
326
+49
+18% +$57K ﹤0.01% 2481
2013
Q4
$276K Hold
277
﹤0.01% 2767
2013
Q3
$289K Buy
277
+9
+3% +$9.62K ﹤0.01% 2715
2013
Q2
$294K Buy
+268
New +$299K ﹤0.01% 2632

Other funds holding VIRX

California State Teachers Retirement System (CalSTRS)'s VIRX Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2022, closing a stake of 15,670 shares — an estimated $75K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in VIRX in Q2 2013 and held it in 12 quarters. The position peaked at $652K in Q3 2014. 63 funds tracked by Wall St. Rank hold VIRX as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 15,670 Viracta Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $75K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Viracta Therapeutics, Inc. Common Stock position peaked at $652K in Q3 2014.
  • 63 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.